Legal & General Group
VRCA icon

Legal & General Group’s Verrica Pharmaceuticals VRCA Stock Holding History

Legal & General Group’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-252
Closed -$1.11K – 3551
2025
Q1 		$1.11K Hold
252
– – ﹤0.01% 3370
2024
Q4 		$1.76K Hold
252
– – ﹤0.01% 3383
2024
Q3 		$3.65K Hold
252
– – ﹤0.01% 3380
2024
Q2 		$18.4K Sell
252
-1
-0.4% -$77 ﹤0.01% 3058
2024
Q1 		$15K Hold
253
– – ﹤0.01% 3088
2023
Q4 		$18.5K Hold
253
– – ﹤0.01% 3064
2023
Q3 		$9.81K Hold
253
– – ﹤0.01% 3272
2023
Q2 		$14.6K Buy
+253
New +$15.4K ﹤0.01% 3234
2022
Q3 		– Sell
-110
Closed -$2K – 3490
2022
Q2 		$2K Sell
110
-34
-24% -$1.71K ﹤0.01% 3492
2022
Q1 		$12K Hold
144
– – ﹤0.01% 3370
2021
Q4 		$13K Hold
144
– – ﹤0.01% 3412
2021
Q3 		$18K Hold
144
– – ﹤0.01% 3315
2021
Q2 		$16K Hold
144
– – ﹤0.01% 3366
2021
Q1 		$22K Sell
144
-12
-8% -$1.66K ﹤0.01% 3104
2020
Q4 		$18K Hold
156
– – ﹤0.01% 3143
2020
Q3 		$12K Sell
156
-60
-28% -$4.92K ﹤0.01% 3171
2020
Q2 		$24K Buy
216
+26
+14% +$3.01K ﹤0.01% 2989
2020
Q1 		$21K Sell
190
-58
-23% -$7.63K ﹤0.01% 2895
2019
Q4 		$39K Buy
248
+59
+31% +$8.71K ﹤0.01% 2922
2019
Q3 		$28K Hold
189
– – ﹤0.01% 3005
2019
Q2 		$18K Hold
189
– – ﹤0.01% 3245
2019
Q1 		$20K Buy
189
+100
+112% +$11.5K ﹤0.01% 3095
2018
Q4 		$7K Hold
89
– – ﹤0.01% 3315
2018
Q3 		$14K Buy
+89
New +$15.2K ﹤0.01% 3283

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Legal & General Group's VRCA Position: Q2 2025 in Review

Legal & General Group sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 252 shares — an estimated $1.11K sold.

Legal & General Group first reported a position in VRCA in Q3 2018 and held it in 24 quarters. The position peaked at $39K in Q4 2019. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Legal & General Group reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 252 Verrica Pharmaceuticals shares in Q2 2025, an estimated $1.11K.
  • Legal & General Group first reported a position in Verrica Pharmaceuticals in Q3 2018 and held it in 24 quarters.
  • Legal & General Group's Verrica Pharmaceuticals position peaked at $39K in Q4 2019.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.